Published on 22 Nov 2023 on Simply Wall St. via Yahoo Finance
Is There An Opportunity With CONMED Corporation's (NYSE:CNMD) 44% Undervaluation?
Key Insights
Using the 2 Stage Free Cash Flow to Equity, CONMED fair value estimate is US$194CONMED is estimated to be 44% undervalued based on current share price of US$108 The US$123 analyst price target for CNMD is 36% less than our estimate of fair value
Today we will run through one way of estimating the intrinsic value of CONMED Corporation (NYSE:CNMD) by taking the expected future cash flows and discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.